<TEXT>
Group Total, # Stage 0, # Stage I, # Stage II, # Stage III, # Stage IV, # Stage ?, # Stage 0, % Stage I, % Stage II, % Stage III, % Stage IV, % Stage ?, % Stage I, % Stage II, % Stage III, % Stage IV, % NHW 91951 17315 36067 23185 7899 3304 4181 18.83 39.22 25.21 8.59 3.59 4.55 51.19 32.91 11.21 4.69 Black 8804 1634 2548 2533 1073 549 467 18.56 28.94 28.77 12.19 6.24 5.3 38.01 37.79 16.01 8.19 Hispanic 22856 4155 6887 6663 2915 988 1248 18.18 30.13 29.15 12.75 4.32 5.46 39.46 38.18 16.7 5.66 Asian/PI 16251 3818 5515 4353 1359 525 681 23.49 33.94 26.79 8.36 3.23 4.19 46.93 37.04 11.56 4.47 Age 20-44 16560 3071 4245 5466 2445 627 706 18.54 25.63 33.01 14.76 3.79 4.26 33.21 42.76 19.13 4.9 Age 45-64 69521 15088 24218 18211 6812 2590 2602 21.7 34.84 26.19 9.8 3.73 3.74 46.72 35.14 13.14 5 Age 65+ 55573 9185 23052 13406 4103 2198 3629 16.53 41.48 24.12 7.38 3.96 6.53 53.91 31.35 9.6 5.14 Table 4. Incidence numbers (column 2 = total, columns 3-7 = stages 0-IV, column 8 = stage unknown or “?”, for each row columns 3 through 8 add up to column 2), incidence rates in % for stages 0-IV and stage unknown (columns 9-13 = stages 0-IV, column 14 = stage unknown, for each row columns 9 through 14 add up to 100% up to rounding to 2 digits), and incidence rates for stages I-IV only with stage 0 and stage unknown specifically excluded (columns 15-18 = stages I-IV, for each row columns 15 through 18 add up to 100% up to rounding to 2 digits). The incidence numbers are based on the data for California women aged 20 and older diagnosed with Breast Cancer during 2005-2009 as reported in [Morris et al, 2013]. The demographic groups are abbreviated as follows: NHW = Non-Hispanic White, PI = Pacific Islander.
</TEXT>
<TABLE>
Cancer      Total, # Stage   Stage    Stage    Stage   Stage   Stage    Stage  Stage   Stage   Stage   Stage  Stage   Stage   Stage   Stage   Stage
                     0, #    I, #     II, #    III, #  IV, #   ?, #     0, %   I, %    II, %   III, %  IV, %  ?, %    I, %    II, %   III, %  IV, %
Breast      260590   49540   96601    67953    24317   10382   11797    19.01  37.07   26.08   9.33    3.98   4.53    48.48   34.1    12.2    5.21
Colon       97947    8235    20085    23615    21597   17961   6454     8.41   20.51   24.11   22.05   18.34  6.59    24.12   28.36   25.94   21.57
Rectum      30334    2814    7536     4794     6081    4242    4867     9.28   24.84   15.8    20.05   13.98  16.04   33.27   21.16   26.84   18.73
Lung        155820   142     27008    7381     31097   69944   20248    0.09   17.33   4.74    19.96   44.89  12.99   19.94   5.45    22.96   51.65
Prostate    198043   NA      16113    135698   14194   13359   18679    NA     8.14    68.52   7.17    6.75   9.43    8.98    75.66   7.91    7.45
</TABLE>
<TEXT>
Table 5. Incidence numbers and rates with the same conventions for columns 2-18 as in Table 4. The incidence numbers are based on the data for persons diagnosed with breast, colon, rectal, lung, and prostate cancer in California during 2004-2012 as reported in [Parikh-Patel et al, 2015]. Some cancer sites in column 1 are abbreviated as follows: Breast = female breast, Rectum = rectum and rectosigmoid junction, Lung = lung and bronchus.
</TEXT>
<PAGE_FOOTER>
20
</PAGE_FOOTER>
<PAGE_BREAK>
